

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 5.71943395 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.13585287 |
| 3 | postsynaptic membrane organization (GO:0001941) | 5.09881125 |
| 4 | presynaptic membrane assembly (GO:0097105) | 4.95929994 |
| 5 | vocalization behavior (GO:0071625) | 4.77170899 |
| 6 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.74605375 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.54456594 |
| 8 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.44028061 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41091729 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.40727544 |
| 11 | response to pheromone (GO:0019236) | 4.37557072 |
| 12 | protein localization to synapse (GO:0035418) | 4.36919238 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.35839529 |
| 14 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.23004285 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.17464780 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.12688661 |
| 17 | synaptic vesicle maturation (GO:0016188) | 4.08703920 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03113950 |
| 19 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.01110305 |
| 20 | glutamate secretion (GO:0014047) | 3.96671949 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.95822393 |
| 22 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.92234643 |
| 23 | surfactant homeostasis (GO:0043129) | 3.91988823 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.88938848 |
| 25 | neurofilament cytoskeleton organization (GO:0060052) | 3.86641164 |
| 26 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83336240 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 3.80561492 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.79277897 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 3.78803811 |
| 30 | lipid particle organization (GO:0034389) | 3.64819811 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.60963313 |
| 32 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.60378714 |
| 33 | cellular response to pH (GO:0071467) | 3.58908794 |
| 34 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.58735301 |
| 35 | transepithelial transport (GO:0070633) | 3.57789357 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.57678524 |
| 37 | detection of calcium ion (GO:0005513) | 3.55725662 |
| 38 | chemical homeostasis within a tissue (GO:0048875) | 3.50672422 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49356370 |
| 40 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.45520071 |
| 41 | positive regulation of action potential (GO:0045760) | 3.43683744 |
| 42 | neuromuscular process controlling posture (GO:0050884) | 3.42597182 |
| 43 | negative regulation of dendrite development (GO:2000171) | 3.41169345 |
| 44 | positive regulation of synapse assembly (GO:0051965) | 3.40979793 |
| 45 | chaperone-mediated protein transport (GO:0072321) | 3.38791995 |
| 46 | respiratory electron transport chain (GO:0022904) | 3.34068245 |
| 47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32766065 |
| 48 | glutamate receptor signaling pathway (GO:0007215) | 3.31309494 |
| 49 | GTP biosynthetic process (GO:0006183) | 3.31144083 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.30605253 |
| 51 | exploration behavior (GO:0035640) | 3.30208963 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 3.28679035 |
| 53 | electron transport chain (GO:0022900) | 3.27673169 |
| 54 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.24763080 |
| 55 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.24080508 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.23955207 |
| 57 | regulation of alkaline phosphatase activity (GO:0010692) | 3.20241484 |
| 58 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.20237342 |
| 59 | neurotransmitter transport (GO:0006836) | 3.16622284 |
| 60 | short-term memory (GO:0007614) | 3.16024012 |
| 61 | regulation of respiratory system process (GO:0044065) | 3.13399274 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 3.10937754 |
| 63 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.10936717 |
| 64 | synapse assembly (GO:0007416) | 3.07157170 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.04582869 |
| 66 | locomotory exploration behavior (GO:0035641) | 3.03303861 |
| 67 | cellular response to cholesterol (GO:0071397) | 3.02231237 |
| 68 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.00915865 |
| 69 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.00801278 |
| 70 | positive regulation of neurotransmitter transport (GO:0051590) | 2.98340847 |
| 71 | proline transport (GO:0015824) | 2.98306166 |
| 72 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.96637395 |
| 73 | ATP synthesis coupled proton transport (GO:0015986) | 2.96637395 |
| 74 | regulation of neurotransmitter levels (GO:0001505) | 2.96098793 |
| 75 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96022601 |
| 76 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.93111449 |
| 77 | innervation (GO:0060384) | 2.92971801 |
| 78 | positive regulation of membrane potential (GO:0045838) | 2.90874933 |
| 79 | regulation of lipoprotein particle clearance (GO:0010984) | 2.88623797 |
| 80 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.87346540 |
| 81 | startle response (GO:0001964) | 2.87030144 |
| 82 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.86916695 |
| 83 | neuromuscular synaptic transmission (GO:0007274) | 2.86674779 |
| 84 | cell migration in hindbrain (GO:0021535) | 2.86472911 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 2.85171686 |
| 86 | striatum development (GO:0021756) | 2.84203545 |
| 87 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.81621060 |
| 88 | membrane assembly (GO:0071709) | 2.81143832 |
| 89 | metanephric nephron tubule development (GO:0072234) | 2.80936039 |
| 90 | metanephric tubule development (GO:0072170) | 2.80936039 |
| 91 | regulation of respiratory gaseous exchange (GO:0043576) | 2.80923088 |
| 92 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.80422056 |
| 93 | NADH dehydrogenase complex assembly (GO:0010257) | 2.80422056 |
| 94 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.80422056 |
| 95 | response to histamine (GO:0034776) | 2.80325911 |
| 96 | neuron recognition (GO:0008038) | 2.79738494 |
| 97 | platelet dense granule organization (GO:0060155) | 2.79643050 |
| 98 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.79486125 |
| 99 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.79454575 |
| 100 | regulation of synapse assembly (GO:0051963) | 2.78318076 |
| 101 | positive regulation of vasculogenesis (GO:2001214) | 2.77431075 |
| 102 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.77429948 |
| 103 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.77429948 |
| 104 | toxin metabolic process (GO:0009404) | 2.77201727 |
| 105 | hindbrain development (GO:0030902) | 2.77061980 |
| 106 | mechanosensory behavior (GO:0007638) | 2.76500523 |
| 107 | membrane depolarization during action potential (GO:0086010) | 2.76465610 |
| 108 | tonic smooth muscle contraction (GO:0014820) | 2.75504371 |
| 109 | negative regulation of appetite (GO:0032099) | 2.74746444 |
| 110 | negative regulation of response to food (GO:0032096) | 2.74746444 |
| 111 | brain morphogenesis (GO:0048854) | 2.74506259 |
| 112 | regulation of vasculogenesis (GO:2001212) | 2.73906368 |
| 113 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.73584244 |
| 114 | response to dietary excess (GO:0002021) | 2.73283431 |
| 115 | long-term synaptic potentiation (GO:0060291) | 2.70915898 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.70176023 |
| 117 | auditory behavior (GO:0031223) | 2.70050427 |
| 118 | regulation of synapse structural plasticity (GO:0051823) | 2.68547626 |
| 119 | regulation of vesicle fusion (GO:0031338) | 2.68155397 |
| 120 | metanephric mesenchyme development (GO:0072075) | 2.67398439 |
| 121 | synaptic transmission (GO:0007268) | 2.67175590 |
| 122 | UTP biosynthetic process (GO:0006228) | 2.66428662 |
| 123 | regulation of postsynaptic membrane potential (GO:0060078) | 2.65862195 |
| 124 | UTP metabolic process (GO:0046051) | 2.65567360 |
| 125 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65234426 |
| 126 | cellular response to sterol (GO:0036315) | 2.63426000 |
| 127 | artery development (GO:0060840) | 2.62269416 |
| 128 | righting reflex (GO:0060013) | 2.62181521 |
| 129 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62170495 |
| 130 | membrane depolarization (GO:0051899) | 2.62155033 |
| 131 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.62129495 |
| 132 | positive regulation of protein kinase C signaling (GO:0090037) | 2.61885041 |
| 133 | smooth muscle tissue development (GO:0048745) | 2.61360018 |
| 134 | response to auditory stimulus (GO:0010996) | 2.61052444 |
| 135 | peripheral nervous system neuron development (GO:0048935) | 2.59646086 |
| 136 | regulation of protein kinase A signaling (GO:0010738) | 2.59197672 |
| 137 | serotonin receptor signaling pathway (GO:0007210) | 2.58890464 |
| 138 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.58228831 |
| 139 | axon ensheathment in central nervous system (GO:0032291) | 2.57148800 |
| 140 | central nervous system myelination (GO:0022010) | 2.57148800 |
| 141 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.55450533 |
| 142 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.55050298 |
| 143 | adult walking behavior (GO:0007628) | 2.54469745 |
| 144 | protein-cofactor linkage (GO:0018065) | 2.53952841 |
| 145 | type B pancreatic cell proliferation (GO:0044342) | 2.53589188 |
| 146 | protein complex biogenesis (GO:0070271) | 2.53356866 |
| 147 | action potential (GO:0001508) | 2.52565905 |
| 148 | urinary tract smooth muscle contraction (GO:0014848) | 2.52200006 |
| 149 | learning (GO:0007612) | 2.52171011 |
| 150 | adult behavior (GO:0030534) | 2.51255493 |
| 151 | artery smooth muscle contraction (GO:0014824) | 2.50968646 |
| 152 | response to gravity (GO:0009629) | 2.48092581 |
| 153 | kidney mesenchyme development (GO:0072074) | 2.46055843 |
| 154 | dendritic spine morphogenesis (GO:0060997) | 2.45449157 |
| 155 | regulation of triglyceride metabolic process (GO:0090207) | 2.45078950 |
| 156 | metanephric nephron epithelium development (GO:0072243) | 2.44123212 |
| 157 | negative regulation of complement activation (GO:0045916) | 2.43104292 |
| 158 | sequestering of actin monomers (GO:0042989) | 2.42255128 |
| 159 | neuronal action potential (GO:0019228) | 2.41003475 |
| 160 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.39961435 |
| 161 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.39563388 |
| 162 | inner ear receptor stereocilium organization (GO:0060122) | 2.38379484 |
| 163 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.38237597 |
| 164 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.37433208 |
| 165 | neurotransmitter catabolic process (GO:0042135) | 2.37325641 |
| 166 | somite rostral/caudal axis specification (GO:0032525) | 2.37019983 |
| 167 | positive regulation of phosphatase activity (GO:0010922) | 2.33278299 |
| 168 | lymphangiogenesis (GO:0001946) | 2.32409004 |
| 169 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.31219686 |
| 170 | axon extension involved in axon guidance (GO:0048846) | 2.31219686 |
| 171 | parturition (GO:0007567) | 2.31162354 |
| 172 | protein heterotrimerization (GO:0070208) | 2.28261432 |
| 173 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.27815092 |
| 174 | amino acid salvage (GO:0043102) | 2.25569039 |
| 175 | L-methionine salvage (GO:0071267) | 2.25569039 |
| 176 | L-methionine biosynthetic process (GO:0071265) | 2.25569039 |
| 177 | regulation of cell communication by electrical coupling (GO:0010649) | 2.25301142 |
| 178 | vascular smooth muscle contraction (GO:0014829) | 2.24972445 |
| 179 | cellular response to leptin stimulus (GO:0044320) | 2.22923983 |
| 180 | response to nitrosative stress (GO:0051409) | 2.21074657 |
| 181 | inositol phosphate-mediated signaling (GO:0048016) | 2.18121401 |
| 182 | axonal fasciculation (GO:0007413) | 2.17861194 |
| 183 | respiratory gaseous exchange (GO:0007585) | 2.17855422 |
| 184 | metanephric epithelium development (GO:0072207) | 2.17323627 |
| 185 | negative regulation of protein activation cascade (GO:2000258) | 2.15389348 |
| 186 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.14225906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.52503622 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.08307663 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01333999 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.80795149 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.25203387 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16416800 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08695838 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.92347927 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72395540 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68344531 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68344531 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68100620 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61518416 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58927717 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.53718252 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51452313 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46035820 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33088992 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31090484 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30818108 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21315275 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20720696 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.19242852 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.10864143 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10644852 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.09637854 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03972710 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.03724773 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03236546 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01206535 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98865967 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96263768 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88362972 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85747880 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81522174 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.79476554 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.69925834 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68541596 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67515022 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67499051 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62084941 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59074760 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57932304 |
| 44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.57556821 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54621206 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.53244852 |
| 47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.53170989 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.52173179 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50658493 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49499134 |
| 51 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.49457420 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49373904 |
| 53 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45831177 |
| 54 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45205710 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45096381 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44280551 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43746001 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41935968 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41446618 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40738657 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39959479 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36985479 |
| 63 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36449073 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34489320 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34384762 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33931642 |
| 67 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29318842 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28531391 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28382815 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28256157 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27507684 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25380853 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24822531 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24501511 |
| 75 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22336559 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21832085 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20131368 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19655087 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19338225 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18754586 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17733192 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16760859 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16199608 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15607705 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14424275 |
| 86 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14290910 |
| 87 | JUN_21703547_ChIP-Seq_K562_Human | 1.13842270 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12293483 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11849873 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11566651 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11391649 |
| 92 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10561614 |
| 93 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09345257 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07963909 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07809546 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07075662 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07037513 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06838109 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06709842 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06571271 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06134285 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05807499 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05807499 |
| 104 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05630806 |
| 105 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05560533 |
| 106 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05299179 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04919963 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04919963 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04407306 |
| 110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02674647 |
| 111 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02253178 |
| 112 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02141570 |
| 113 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01526969 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01348119 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00652306 |
| 116 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00147099 |
| 117 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99754579 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98805575 |
| 119 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98711145 |
| 120 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98633711 |
| 121 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98544908 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97713098 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.96975395 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96855770 |
| 125 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96151593 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95771915 |
| 127 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95122920 |
| 128 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95122920 |
| 129 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94972073 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93617870 |
| 131 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93150867 |
| 132 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91577152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.47526373 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.23013883 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.80773934 |
| 4 | MP0009046_muscle_twitch | 3.59450502 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.39261878 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.28294244 |
| 7 | MP0005503_abnormal_tendon_morphology | 3.19155941 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.13413817 |
| 9 | MP0006276_abnormal_autonomic_nervous | 3.08762131 |
| 10 | MP0004270_analgesia | 2.98120035 |
| 11 | MP0009745_abnormal_behavioral_response | 2.97777767 |
| 12 | MP0002064_seizures | 2.81198702 |
| 13 | MP0002736_abnormal_nociception_after | 2.78134434 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.63429468 |
| 15 | MP0002272_abnormal_nervous_system | 2.53978416 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.47440509 |
| 17 | MP0009379_abnormal_foot_pigmentation | 2.46819364 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.44397595 |
| 19 | MP0001486_abnormal_startle_reflex | 2.43355645 |
| 20 | MP0001188_hyperpigmentation | 2.40116642 |
| 21 | MP0001958_emphysema | 2.38836601 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.25078602 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.23380300 |
| 24 | MP0003283_abnormal_digestive_organ | 2.20074506 |
| 25 | MP0005275_abnormal_skin_tensile | 2.17616586 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.15266488 |
| 27 | MP0003950_abnormal_plasma_membrane | 2.10939911 |
| 28 | MP0001970_abnormal_pain_threshold | 2.08834406 |
| 29 | MP0001986_abnormal_taste_sensitivity | 2.03096341 |
| 30 | MP0002184_abnormal_innervation | 1.94950600 |
| 31 | MP0008569_lethality_at_weaning | 1.92111130 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.91457576 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.85388013 |
| 34 | MP0001542_abnormal_bone_strength | 1.85343091 |
| 35 | MP0004142_abnormal_muscle_tone | 1.84434036 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.84142146 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.83898990 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.82762023 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.78926833 |
| 40 | MP0004858_abnormal_nervous_system | 1.77802940 |
| 41 | MP0002822_catalepsy | 1.69819967 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.62871861 |
| 43 | MP0005595_abnormal_vascular_smooth | 1.54836146 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.53865377 |
| 45 | MP0004924_abnormal_behavior | 1.53865377 |
| 46 | MP0001905_abnormal_dopamine_level | 1.52166713 |
| 47 | MP0005409_darkened_coat_color | 1.51545991 |
| 48 | MP0000778_abnormal_nervous_system | 1.49405214 |
| 49 | MP0001984_abnormal_olfaction | 1.49361536 |
| 50 | MP0002295_abnormal_pulmonary_circulatio | 1.44829062 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.43596404 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.43295784 |
| 53 | MP0003136_yellow_coat_color | 1.42099424 |
| 54 | MP0004043_abnormal_pH_regulation | 1.40497172 |
| 55 | MP0003879_abnormal_hair_cell | 1.39456895 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.39175091 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.38462365 |
| 58 | MP0003011_delayed_dark_adaptation | 1.34384269 |
| 59 | MP0001529_abnormal_vocalization | 1.33363975 |
| 60 | MP0003646_muscle_fatigue | 1.31887670 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.30556255 |
| 62 | MP0000955_abnormal_spinal_cord | 1.30534138 |
| 63 | MP0005670_abnormal_white_adipose | 1.28710261 |
| 64 | MP0010030_abnormal_orbit_morphology | 1.26497616 |
| 65 | MP0004811_abnormal_neuron_physiology | 1.25444595 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.25008030 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.24953085 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 1.23748823 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.21576644 |
| 70 | MP0002751_abnormal_autonomic_nervous | 1.21057923 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 1.20626672 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.20013146 |
| 73 | MP0003122_maternal_imprinting | 1.18997161 |
| 74 | MP0000230_abnormal_systemic_arterial | 1.17163338 |
| 75 | MP0000751_myopathy | 1.15919689 |
| 76 | MP0001963_abnormal_hearing_physiology | 1.15893314 |
| 77 | MP0005360_urolithiasis | 1.13271283 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.09836715 |
| 79 | MP0005332_abnormal_amino_acid | 1.08652352 |
| 80 | MP0005620_abnormal_muscle_contractility | 1.07977957 |
| 81 | MP0005508_abnormal_skeleton_morphology | 1.07906038 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.07621840 |
| 83 | MP0003252_abnormal_bile_duct | 1.07145071 |
| 84 | MP0006292_abnormal_olfactory_placode | 1.04527692 |
| 85 | MP0010386_abnormal_urinary_bladder | 1.03144784 |
| 86 | MP0004272_abnormal_basement_membrane | 1.02738277 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.02230126 |
| 88 | MP0002102_abnormal_ear_morphology | 1.00419026 |
| 89 | MP0002928_abnormal_bile_duct | 0.99847803 |
| 90 | MP0000026_abnormal_inner_ear | 0.98313697 |
| 91 | MP0005365_abnormal_bile_salt | 0.98173473 |
| 92 | MP0002938_white_spotting | 0.96559524 |
| 93 | MP0004484_altered_response_of | 0.96484477 |
| 94 | MP0003633_abnormal_nervous_system | 0.95718356 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.95638441 |
| 96 | MP0005164_abnormal_response_to | 0.95578346 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.94908065 |
| 98 | MP0002282_abnormal_trachea_morphology | 0.94800629 |
| 99 | MP0003787_abnormal_imprinting | 0.93749567 |
| 100 | MP0003195_calcinosis | 0.93690866 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.93609660 |
| 102 | MP0003938_abnormal_ear_development | 0.91996692 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.90886971 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.90358393 |
| 105 | MP0002752_abnormal_somatic_nervous | 0.90312055 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89577231 |
| 107 | MP0000427_abnormal_hair_cycle | 0.89120090 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.88487153 |
| 109 | MP0008995_early_reproductive_senescence | 0.88253252 |
| 110 | MP0004742_abnormal_vestibular_system | 0.87373479 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.87028126 |
| 112 | MP0001270_distended_abdomen | 0.86973719 |
| 113 | MP0000383_abnormal_hair_follicle | 0.86935176 |
| 114 | MP0004133_heterotaxia | 0.86747500 |
| 115 | MP0005171_absent_coat_pigmentation | 0.85153861 |
| 116 | MP0003329_amyloid_beta_deposits | 0.84914640 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.84697301 |
| 118 | MP0002909_abnormal_adrenal_gland | 0.82287962 |
| 119 | MP0003868_abnormal_feces_composition | 0.82245832 |
| 120 | MP0002229_neurodegeneration | 0.82171782 |
| 121 | MP0002009_preneoplasia | 0.81810535 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.81174700 |
| 123 | MP0005499_abnormal_olfactory_system | 0.81129325 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.81129325 |
| 125 | MP0000631_abnormal_neuroendocrine_gland | 0.79608688 |
| 126 | MP0002152_abnormal_brain_morphology | 0.78714568 |
| 127 | MP0009250_abnormal_appendicular_skeleto | 0.78551461 |
| 128 | MP0004883_abnormal_blood_vessel | 0.77283787 |
| 129 | MP0004885_abnormal_endolymph | 0.77243581 |
| 130 | MP0002234_abnormal_pharynx_morphology | 0.76645491 |
| 131 | MP0000049_abnormal_middle_ear | 0.76188928 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.75478186 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.75394115 |
| 134 | MP0001756_abnormal_urination | 0.74810454 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.74773988 |
| 136 | MP0005187_abnormal_penis_morphology | 0.74630818 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.74288261 |
| 138 | MP0001664_abnormal_digestion | 0.73116901 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.72778820 |
| 140 | MP0010678_abnormal_skin_adnexa | 0.72714385 |
| 141 | MP0008872_abnormal_physiological_respon | 0.72459477 |
| 142 | MP0003183_abnormal_peptide_metabolism | 0.72267948 |
| 143 | MP0004085_abnormal_heartbeat | 0.72155100 |
| 144 | MP0005535_abnormal_body_temperature | 0.71537798 |
| 145 | MP0009780_abnormal_chondrocyte_physiolo | 0.71456438 |
| 146 | MP0008260_abnormal_autophagy | 0.70616202 |
| 147 | MP0003631_nervous_system_phenotype | 0.70457957 |
| 148 | MP0004147_increased_porphyrin_level | 0.69929388 |
| 149 | MP0008874_decreased_physiological_sensi | 0.65349607 |
| 150 | MP0000566_synostosis | 0.63777037 |
| 151 | MP0008789_abnormal_olfactory_epithelium | 0.63441913 |
| 152 | MP0001943_abnormal_respiration | 0.61682349 |
| 153 | MP0003634_abnormal_glial_cell | 0.60970194 |
| 154 | MP0005551_abnormal_eye_electrophysiolog | 0.60898700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.69664660 |
| 2 | Myokymia (HP:0002411) | 5.96996867 |
| 3 | Febrile seizures (HP:0002373) | 5.81986257 |
| 4 | Atonic seizures (HP:0010819) | 5.72032491 |
| 5 | Focal seizures (HP:0007359) | 4.46052619 |
| 6 | Hypothermia (HP:0002045) | 4.41228795 |
| 7 | Neuroendocrine neoplasm (HP:0100634) | 4.18856425 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.15127758 |
| 9 | Pheochromocytoma (HP:0002666) | 4.08602199 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 4.05990604 |
| 11 | Absence seizures (HP:0002121) | 3.98499974 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.89569278 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.77615779 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.76963350 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.74939732 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.62420296 |
| 17 | Action tremor (HP:0002345) | 3.53066375 |
| 18 | Dialeptic seizures (HP:0011146) | 3.53031837 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.41733493 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.21876500 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.21876500 |
| 22 | Visual hallucinations (HP:0002367) | 3.19794636 |
| 23 | Progressive inability to walk (HP:0002505) | 3.15462487 |
| 24 | Ulnar claw (HP:0001178) | 3.14545421 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.14029280 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.12869209 |
| 27 | Acute encephalopathy (HP:0006846) | 3.10095007 |
| 28 | Hyperventilation (HP:0002883) | 3.06884631 |
| 29 | Increased CSF lactate (HP:0002490) | 3.06508182 |
| 30 | Optic disc pallor (HP:0000543) | 2.91775044 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.89715024 |
| 32 | Limb dystonia (HP:0002451) | 2.88108981 |
| 33 | Congenital, generalized hypertrichosis (HP:0004540) | 2.84184589 |
| 34 | Poor suck (HP:0002033) | 2.83443471 |
| 35 | Global brain atrophy (HP:0002283) | 2.81266834 |
| 36 | Medial flaring of the eyebrow (HP:0010747) | 2.77209215 |
| 37 | Anxiety (HP:0000739) | 2.76919986 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.74455067 |
| 39 | Gait imbalance (HP:0002141) | 2.74252197 |
| 40 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.73432594 |
| 41 | Hydroxyprolinuria (HP:0003080) | 2.68967064 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 2.68967064 |
| 43 | Hepatic necrosis (HP:0002605) | 2.62505315 |
| 44 | Tachypnea (HP:0002789) | 2.56756480 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.56391891 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.55916037 |
| 47 | Congenital primary aphakia (HP:0007707) | 2.54183077 |
| 48 | Diplopia (HP:0000651) | 2.51732306 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.51732306 |
| 50 | Broad-based gait (HP:0002136) | 2.48956300 |
| 51 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47071733 |
| 52 | Depression (HP:0000716) | 2.46965582 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.45312089 |
| 54 | Abnormal hair whorl (HP:0010721) | 2.43580811 |
| 55 | Atrioventricular block (HP:0001678) | 2.43274196 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.41702471 |
| 57 | Tubulointerstitial fibrosis (HP:0005576) | 2.38505024 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.36381171 |
| 59 | Amblyopia (HP:0000646) | 2.36313265 |
| 60 | Respiratory distress (HP:0002098) | 2.31384482 |
| 61 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29412858 |
| 62 | Genital tract atresia (HP:0001827) | 2.28220188 |
| 63 | True hermaphroditism (HP:0010459) | 2.22599323 |
| 64 | Scanning speech (HP:0002168) | 2.21024060 |
| 65 | Abnormal atrioventricular conduction (HP:0005150) | 2.19347905 |
| 66 | Keratoconus (HP:0000563) | 2.18605407 |
| 67 | Increased corneal curvature (HP:0100692) | 2.18605407 |
| 68 | Vaginal atresia (HP:0000148) | 2.18357920 |
| 69 | Clumsiness (HP:0002312) | 2.15876453 |
| 70 | Exercise intolerance (HP:0003546) | 2.15663759 |
| 71 | Exertional dyspnea (HP:0002875) | 2.14037401 |
| 72 | Heart block (HP:0012722) | 2.13761450 |
| 73 | Pancreatic cysts (HP:0001737) | 2.13083206 |
| 74 | Bradycardia (HP:0001662) | 2.11588200 |
| 75 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11533123 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10584408 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.10584408 |
| 78 | Hyperalaninemia (HP:0003348) | 2.10584408 |
| 79 | X-linked dominant inheritance (HP:0001423) | 2.09276458 |
| 80 | Hemiparesis (HP:0001269) | 2.08203607 |
| 81 | Inability to walk (HP:0002540) | 2.06784640 |
| 82 | Progressive external ophthalmoplegia (HP:0000590) | 2.02932831 |
| 83 | Respiratory failure (HP:0002878) | 2.02683607 |
| 84 | Dysdiadochokinesis (HP:0002075) | 2.02405516 |
| 85 | Skin nodule (HP:0200036) | 2.01933109 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.01741173 |
| 87 | Bundle branch block (HP:0011710) | 2.01703371 |
| 88 | Nonprogressive disorder (HP:0003680) | 2.01323853 |
| 89 | Excessive salivation (HP:0003781) | 2.00505925 |
| 90 | Drooling (HP:0002307) | 2.00505925 |
| 91 | Prolonged QT interval (HP:0001657) | 2.00237730 |
| 92 | Polyphagia (HP:0002591) | 1.99124618 |
| 93 | Nephronophthisis (HP:0000090) | 1.98688805 |
| 94 | Bone cyst (HP:0012062) | 1.98500377 |
| 95 | Aortic aneurysm (HP:0004942) | 1.98478638 |
| 96 | Specific learning disability (HP:0001328) | 1.97629620 |
| 97 | Truncal ataxia (HP:0002078) | 1.96277975 |
| 98 | Hyperaldosteronism (HP:0000859) | 1.95710066 |
| 99 | Hypoventilation (HP:0002791) | 1.95377921 |
| 100 | Emotional lability (HP:0000712) | 1.93909682 |
| 101 | Atrial fibrillation (HP:0005110) | 1.93337681 |
| 102 | Steppage gait (HP:0003376) | 1.93245596 |
| 103 | Lactic acidosis (HP:0003128) | 1.92387181 |
| 104 | Increased hepatocellular lipid droplets (HP:0006565) | 1.91795518 |
| 105 | Failure to thrive in infancy (HP:0001531) | 1.91750211 |
| 106 | Hemiplegia (HP:0002301) | 1.90396718 |
| 107 | Abnormality of the vertebral endplates (HP:0005106) | 1.90185146 |
| 108 | Abnormality of the vocal cords (HP:0008777) | 1.89327185 |
| 109 | Dysmetria (HP:0001310) | 1.89143145 |
| 110 | Increased serum lactate (HP:0002151) | 1.88978065 |
| 111 | Esotropia (HP:0000565) | 1.88521913 |
| 112 | Cortical visual impairment (HP:0100704) | 1.87548299 |
| 113 | Ventricular fibrillation (HP:0001663) | 1.87543132 |
| 114 | Type II lissencephaly (HP:0007260) | 1.86833897 |
| 115 | Cystic liver disease (HP:0006706) | 1.85313549 |
| 116 | Primary atrial arrhythmia (HP:0001692) | 1.85240608 |
| 117 | Retinal dysplasia (HP:0007973) | 1.84943415 |
| 118 | Fair hair (HP:0002286) | 1.84850753 |
| 119 | Agitation (HP:0000713) | 1.84278190 |
| 120 | Megalencephaly (HP:0001355) | 1.83449697 |
| 121 | Absent speech (HP:0001344) | 1.82942621 |
| 122 | Hypercalciuria (HP:0002150) | 1.82652966 |
| 123 | Short tibia (HP:0005736) | 1.82635994 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.81639112 |
| 125 | Metabolic alkalosis (HP:0200114) | 1.80811513 |
| 126 | Prominent supraorbital ridges (HP:0000336) | 1.80129272 |
| 127 | Hypercortisolism (HP:0001578) | 1.80073488 |
| 128 | Status epilepticus (HP:0002133) | 1.79418064 |
| 129 | Blue irides (HP:0000635) | 1.78980145 |
| 130 | Bilateral microphthalmos (HP:0007633) | 1.78625607 |
| 131 | Supraventricular tachycardia (HP:0004755) | 1.77511220 |
| 132 | Cerebral inclusion bodies (HP:0100314) | 1.77306304 |
| 133 | Intention tremor (HP:0002080) | 1.77207339 |
| 134 | Vascular tortuosity (HP:0004948) | 1.77041517 |
| 135 | Severe muscular hypotonia (HP:0006829) | 1.75729192 |
| 136 | Increased serum pyruvate (HP:0003542) | 1.75645542 |
| 137 | Abnormality of glycolysis (HP:0004366) | 1.75645542 |
| 138 | Poor eye contact (HP:0000817) | 1.73597127 |
| 139 | Cerebral edema (HP:0002181) | 1.73592907 |
| 140 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.73537520 |
| 141 | Mutism (HP:0002300) | 1.73068833 |
| 142 | Myotonia (HP:0002486) | 1.71655668 |
| 143 | Supraventricular arrhythmia (HP:0005115) | 1.71524336 |
| 144 | Impaired social interactions (HP:0000735) | 1.71163134 |
| 145 | Abnormal social behavior (HP:0012433) | 1.71163134 |
| 146 | Irregular vertebral endplates (HP:0003301) | 1.70719951 |
| 147 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.69313394 |
| 148 | Delayed gross motor development (HP:0002194) | 1.68010713 |
| 149 | Fibular hypoplasia (HP:0003038) | 1.67579835 |
| 150 | Abnormality of the axillary hair (HP:0100134) | 1.67285537 |
| 151 | Abnormality of secondary sexual hair (HP:0009888) | 1.67285537 |
| 152 | Amelogenesis imperfecta (HP:0000705) | 1.66303977 |
| 153 | Abnormality of dental color (HP:0011073) | 1.65946572 |
| 154 | Generalized aminoaciduria (HP:0002909) | 1.65770446 |
| 155 | Abnormality of the renal medulla (HP:0100957) | 1.65703398 |
| 156 | Redundant skin (HP:0001582) | 1.64874576 |
| 157 | Renal Fanconi syndrome (HP:0001994) | 1.63972138 |
| 158 | Epidermoid cyst (HP:0200040) | 1.63669113 |
| 159 | Hypoplastic toenails (HP:0001800) | 1.63620350 |
| 160 | Congenital stationary night blindness (HP:0007642) | 1.63343467 |
| 161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.63248223 |
| 162 | Cerebellar dysplasia (HP:0007033) | 1.60201721 |
| 163 | Pulmonary artery stenosis (HP:0004415) | 1.59230311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.24512329 |
| 2 | NTRK3 | 4.09640240 |
| 3 | MAP3K12 | 4.00875567 |
| 4 | MAP2K7 | 3.38858144 |
| 5 | TNIK | 2.82706775 |
| 6 | MINK1 | 2.74281445 |
| 7 | MST1R | 2.73469139 |
| 8 | MAP3K4 | 2.61218037 |
| 9 | EPHA4 | 2.20612649 |
| 10 | MUSK | 2.07902797 |
| 11 | STK38 | 2.06858839 |
| 12 | GRK5 | 1.92297936 |
| 13 | EPHB2 | 1.91049665 |
| 14 | MAP3K9 | 1.85420239 |
| 15 | MET | 1.85038258 |
| 16 | ABL2 | 1.83816289 |
| 17 | CDK19 | 1.74752754 |
| 18 | MAP2K4 | 1.68725976 |
| 19 | LMTK2 | 1.63514412 |
| 20 | MAPK13 | 1.60439755 |
| 21 | GRK7 | 1.57769656 |
| 22 | PRPF4B | 1.55976540 |
| 23 | PAK3 | 1.55537892 |
| 24 | TSSK6 | 1.45751356 |
| 25 | PLK2 | 1.44597757 |
| 26 | ZAK | 1.37515842 |
| 27 | MARK1 | 1.34729888 |
| 28 | SGK2 | 1.30530102 |
| 29 | PIM2 | 1.28194832 |
| 30 | TNK2 | 1.24320623 |
| 31 | DAPK2 | 1.24173436 |
| 32 | PRKD2 | 1.18189863 |
| 33 | CAMK2A | 1.16406554 |
| 34 | CSNK1G1 | 1.16024485 |
| 35 | TESK1 | 1.15730638 |
| 36 | PRKCG | 1.14278796 |
| 37 | FRK | 1.13930687 |
| 38 | SGK223 | 1.11675167 |
| 39 | SGK494 | 1.11675167 |
| 40 | MAP4K2 | 1.11641940 |
| 41 | TIE1 | 1.11630620 |
| 42 | STK39 | 1.11442305 |
| 43 | WNK4 | 1.09934728 |
| 44 | NTRK1 | 1.09635971 |
| 45 | CAMKK2 | 1.09542234 |
| 46 | CSNK1G3 | 1.09084017 |
| 47 | ARAF | 1.08149416 |
| 48 | PHKG1 | 1.07751009 |
| 49 | PHKG2 | 1.07751009 |
| 50 | ERBB3 | 1.06983926 |
| 51 | RIPK4 | 1.05315559 |
| 52 | NTRK2 | 1.03607662 |
| 53 | CSNK1A1L | 1.00354193 |
| 54 | OXSR1 | 1.00005432 |
| 55 | DYRK2 | 0.97109077 |
| 56 | CDK5 | 0.96932985 |
| 57 | SIK3 | 0.94065060 |
| 58 | WNK1 | 0.93842488 |
| 59 | BMPR2 | 0.93482767 |
| 60 | PRKCE | 0.93125323 |
| 61 | NME1 | 0.92938829 |
| 62 | CAMK2B | 0.92549636 |
| 63 | ADRBK1 | 0.91951748 |
| 64 | MKNK2 | 0.91449813 |
| 65 | PKN1 | 0.89276275 |
| 66 | LIMK1 | 0.86314363 |
| 67 | DMPK | 0.86113044 |
| 68 | PNCK | 0.85978376 |
| 69 | MYLK | 0.84603797 |
| 70 | YES1 | 0.84381151 |
| 71 | UHMK1 | 0.82603294 |
| 72 | FES | 0.82494761 |
| 73 | BMPR1B | 0.77470112 |
| 74 | TESK2 | 0.77419024 |
| 75 | RAF1 | 0.76710586 |
| 76 | DAPK1 | 0.76520036 |
| 77 | MAPK15 | 0.74010050 |
| 78 | CAMKK1 | 0.72107591 |
| 79 | PDK2 | 0.71322301 |
| 80 | STK11 | 0.70580321 |
| 81 | CAMK2G | 0.69830305 |
| 82 | MAP3K11 | 0.68839564 |
| 83 | MAPKAPK3 | 0.68602731 |
| 84 | ADRBK2 | 0.68470138 |
| 85 | MAPKAPK5 | 0.67619179 |
| 86 | WNK3 | 0.66974359 |
| 87 | DDR2 | 0.66682911 |
| 88 | EPHA2 | 0.62635978 |
| 89 | PRKACB | 0.59869959 |
| 90 | ROCK1 | 0.59408231 |
| 91 | CDK14 | 0.58362009 |
| 92 | INSRR | 0.58023207 |
| 93 | AKT3 | 0.57949745 |
| 94 | PRKG1 | 0.57916927 |
| 95 | MST4 | 0.57019722 |
| 96 | PTK2B | 0.56896109 |
| 97 | HIPK2 | 0.56657331 |
| 98 | PAK2 | 0.56068032 |
| 99 | CAMK1 | 0.55938670 |
| 100 | CAMK2D | 0.55873143 |
| 101 | PAK6 | 0.55817302 |
| 102 | FGR | 0.55674981 |
| 103 | FER | 0.55643486 |
| 104 | IRAK1 | 0.55366566 |
| 105 | PINK1 | 0.55024108 |
| 106 | GSK3A | 0.54690590 |
| 107 | EIF2AK3 | 0.54373070 |
| 108 | KSR1 | 0.54355105 |
| 109 | EIF2AK2 | 0.54290692 |
| 110 | NEK9 | 0.54058973 |
| 111 | STK24 | 0.53787854 |
| 112 | NLK | 0.51463344 |
| 113 | CDK8 | 0.51203476 |
| 114 | KSR2 | 0.50927533 |
| 115 | CDK18 | 0.50475115 |
| 116 | DAPK3 | 0.49754559 |
| 117 | PRKCI | 0.49665326 |
| 118 | TGFBR1 | 0.49545193 |
| 119 | FGFR2 | 0.49080608 |
| 120 | ERBB4 | 0.47805394 |
| 121 | CDK3 | 0.47289768 |
| 122 | PRKACA | 0.46961519 |
| 123 | LATS1 | 0.46674904 |
| 124 | DYRK1A | 0.46147929 |
| 125 | IRAK3 | 0.46034631 |
| 126 | NEK2 | 0.45186202 |
| 127 | BCR | 0.44510695 |
| 128 | MAP2K1 | 0.43675734 |
| 129 | CDK15 | 0.43210701 |
| 130 | SGK3 | 0.42708278 |
| 131 | RPS6KA5 | 0.41876259 |
| 132 | TGFBR2 | 0.41386281 |
| 133 | MAP3K13 | 0.41357764 |
| 134 | GRK6 | 0.41021641 |
| 135 | GRK1 | 0.39716644 |
| 136 | RPS6KA2 | 0.38203744 |
| 137 | CDK11A | 0.37426808 |
| 138 | SGK1 | 0.36376315 |
| 139 | MAP3K1 | 0.36259011 |
| 140 | CSNK1G2 | 0.34362467 |
| 141 | IRAK2 | 0.34165550 |
| 142 | TLK1 | 0.32530271 |
| 143 | SIK2 | 0.31609405 |
| 144 | LATS2 | 0.30893985 |
| 145 | TAOK2 | 0.29799906 |
| 146 | MAP3K2 | 0.29548769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80148627 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.49714050 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30629915 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.80450746 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.63748550 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.54227090 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.50954375 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.50594930 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.44088321 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.42432095 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.38793383 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.38728410 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.38367507 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.38082947 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.18941638 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.14143048 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13002235 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 2.09411450 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06446276 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04844918 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04272206 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.98323134 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.94671556 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89483749 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87139887 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.80511628 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.80331428 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79069738 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77520245 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.77374447 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74685636 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.71248446 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.70416855 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66471229 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.62179189 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61069065 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55986125 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54604307 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46530745 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45510825 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.43103024 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.42629013 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42153861 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42146625 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40333748 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.34470348 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30191862 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.30082854 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.28941134 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25521619 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.21537361 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21222993 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20789941 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19511461 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16676223 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16272488 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15218372 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14617601 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14333511 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12588190 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 1.11468818 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 1.11028040 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10140147 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 1.07377306 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07100565 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05440184 |
| 67 | Gap junction_Homo sapiens_hsa04540 | 1.05313570 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.02889279 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02711780 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98981210 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97557181 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95700703 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94513229 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.93669291 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.92779775 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91000768 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90828186 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87774732 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87268579 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85286093 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85282378 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83326594 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82272631 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82149158 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80435004 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79967630 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79707555 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77867450 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77376763 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77187919 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.76689411 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74088246 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73038443 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71886474 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71535987 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66368537 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65070963 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63916875 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63555193 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62922355 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62362671 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57108961 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56623889 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56559409 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56480123 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55773962 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55747261 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.55535074 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53991075 |
| 110 | Ribosome_Homo sapiens_hsa03010 | 0.53193094 |
| 111 | RNA polymerase_Homo sapiens_hsa03020 | 0.53009935 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53001541 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52235733 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50887762 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50012308 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46877562 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45380684 |
| 118 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45103560 |
| 119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44647994 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.44631915 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43734687 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43671521 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42541060 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.42146150 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.39309492 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.39181034 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39134725 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38854956 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38132761 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36839786 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.36730213 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35672919 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35584174 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31729804 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30406046 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30181414 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29336876 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.29254980 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28895164 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27697235 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27512964 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26405497 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24272016 |
| 144 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.24178760 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22778061 |
| 146 | Protein export_Homo sapiens_hsa03060 | 0.21678887 |
| 147 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.15318839 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14479684 |
| 149 | Endocytosis_Homo sapiens_hsa04144 | 0.14386061 |
| 150 | Colorectal cancer_Homo sapiens_hsa05210 | 0.12891728 |
| 151 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12513161 |

